High levels of anti-HIV-1 envelope antibodies in cerebrospinal fluid as compared to serum from patients with AIDS dementia complex

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 1, 1996, Pages 19-25

  Trujillo, J Roberto ^a   Navia, Bradford A ^b   Worth, Jonathan ^b   Lucey, Daniel R ^c   McLane, Mary Frances ^a   Lee, Tun Hou ^a   Essex, Max ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

AIDS dementia complex; Cerebrospinal fluid; HIV 1 gp120 antibodies

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS ENVELOPE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MARTES PENNANTI;

EID: 0029978054     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199605010-00003     Document Type: Article

References (50)

1. Price RW, Brew B, Sidtis JJ, Rosenblum M, Sheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-92.
2. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517-24.
3. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neuol 1986;19:525-35.
4. Ho DD, Rota TR, Schooley RT, et al. Isolation of HLTV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493-7.
5. Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 1985;2:586-8.
6. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992;42:1472-6.
7. Bacellar H, Muñoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multi-center AIDS Cohort Study, 1985-1992. Neurology 1994;44:1892-900.
8. Shaw GM, Harper ME, Hahn BH, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985;227:177-82.
9. Stoler MH, Eskin TA, Benn S, Angerer RC, Angerer LM. Human T cell lymphotropic virus type III infection of the central nervous system: a preliminary in situ analysis. JAMA 1986;256:2360-4.
10. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-93.
11. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen IS. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990;343:85-9.
12. Brenneman DE, Westbrook GL, Fitzgerald SP, et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988;335:639-42.
13. Toggas SM, Masliah E, Rockenstein EM, Rail OF, Abraham CR, Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice. Nature 1994;367:188-93.
14. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990;248:364-7.
15. Lipton SA. HIV displays its coat of arms. Nature 1994;367:113-4.
16. Resnick L, diMarzo-Veronese F, Schupbach J, et al. Intrablood-brain-barrier synthesis of HTLV-III specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med 1985;313:1498-504.
17. Goudsmit J, Wolters EC, Bakker M, et al. Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Br Med J 1986;292:1231-4.
18. Goudsmit J, Epstein LG, Paul DA, et al. Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees. Proc Natl Acad Sci USA 1987;84:3876-80.
19. Ceroni M, Minoli L, Di Perri G, et al. Detection of HTLV-III-specific IgG bands in the CSF from a patient with AIDS and encephalitis. Neurology 1988;38:143-4.
20. Elovaara I, Seppala I, Poutiainen E, Suni J, Valle SL. Intrathecal humoral immunologie response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection. Neurology 1988;38:1451-6.
21. Chiodi F, Sönnerborg A, Albert J, et al. Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions. J Neurol Sci 1988;85:245-57.
22. Bukasa KS, Sindic CJM, Bodeus M, Burtonboy G, Laterre C, Sonnet J. Anti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study. J Neurol Neurosurg Psychiatry 1988;51:1063-8.
23. Biniek R, Bartholome M, Schulz M, et al. Intrathecal production of HIV antibodies in suspected AIDS encephalopathy. J Neurol 1988;235:131-5.
24. Van Wielink G, McArthur JC, Moench T, et al. Intrathecal synthesis of anti-HIV IgG: correlation with increasing duration of HIV-1 infection. Neurology 1990;40:816-9.
25. Lucey DR, VanCott TC, Loomis LD, et al. Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop). J Acquir Immune Defic Syndr 1993;6:994-1001.
26. Mathiesen T, Sonnerborg A, Trojnar J, Wahren B. Fine analysis of intrathecally synthesized anti-HIV-1 IgG14 by peptide mapping. J Neurol Sci 1990;100:31-6.
27. Elovaara I, Iivanainen M, Valle SL, Suni J, Tervo T, Lahdevirta J. CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. J Neurol Sci 1987;78:331-42.
28. Gallo P, De Rossi A, Amadori A, Tavolato B, Chieco-Bianchi L. Central nervous system involvement in HIV infection. AIDS Res Hum Retroviruses 1988;4:211-21.
29. Goswami KK, Kaye S, Miller R, McAllister R, Tedder R. Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS disease. J Med Virol 1991;33:106-13.
30. Grimaldi LME, Roos RP, Devare SG, et al. Restricted heterogeneity of antibodies to gp120 and p24 in AIDS. J Immunol 1988;141:114-7.
31. Heyes MP, Brew BJ, Martin A, et al. Quinolmic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 1991;29:202-9.
32. 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection. AIDS 1989;3:277-83.
33. Fuchs D, Chiodi F, Albert J, et al. Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS 1989;3:285-8.
34. McArthur JC, Nance-Sproson TE, Griffin DE, et al. The diagnostic utility of elevation in cerebrospinal fluid 2microglobulin in HIV-1 dementia. Neurology 1992;42:1707-12.
35. Griffin DE, McArthur JC, Cornblath DR. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 1991;41:69-74.
36. Grimaldi LME, Martino GV, Franciotta DM, et al. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 1991;29:21-5.
37. Chou MJ, Lee TH, Hatzakis A, Mandalaki T, McLane MF, Essex M. Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis 1988;157:805-11.
38. Syu WJ, Du B, Essex M, et al. Association between crossreactive HIV-1 gp120 antibody and disease progression in HIV-1 infection. In: Vaccine's 1990. Cold Spring Harbor; Cold Spring Harbor Laboratories, 1990:243-7.
39. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
40. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-83.
41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
42. Barin F, M'Boup S, Denis F, et al. Serological evidence for virus related to simian T-lymphotrppic retrovirus III in residents of west Africa. Lancet 1985;2:1387-9.
43. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen ISY. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987;236:819-22.
44. Power C, McArthur JC, Johnson RT, et al. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. 3 Virol 1994;68:4643-9.
45. Korber BTM, Kuntsman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994;68:7467-81.
46. Kuiken CL, Goudsmit J, Weiller GF, et al. Differences in human immunodeficiency virus type l V3 sequences from patients with and without AIDS dementia complex. J Gen Virol 1995;76:175-80.
47. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991;253:71-4.
48. Trujillo JR, Wang WK, Lee TH, Essex M. Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1 virology (in press).
49. Trujillo JR, McLane MF, Lee TH, Essex M. Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins. J Virol 1993;67:7711-5.
50. Trujillo JR, Navia B, Worth J, McLane MF, Lee TH, Essex M. Evaluation of autoantibodies to brain proteins in patients with AIDS dementia complex. J Acquir Immune Defic Syndr 1994 ;7:103-8.